Skip to main content
Vaccinex, Inc. (VCNX)
NASDAQ: VCNX · Real-Time Price · USD
3.240
+0.290 (9.83%)
Nov 4, 2024, 4:00 PM EST - Market closed

Vaccinex Revenue

Vaccinex had revenue of $232.00K in the quarter ending June 30, 2024. This brings the company's revenue in the last twelve months to $356.00K, down -56.85% year-over-year. In the year 2023, Vaccinex had annual revenue of $570.00K with 107.27% growth.

Revenue (ttm)
$356.00K
Revenue Growth
-56.85%
P/S Ratio
9.27
Revenue / Employee
$8,900
Employees
40
Market Cap
8.42M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023570.00K295.00K107.27%
Dec 31, 2022275.00K-625.00K-69.44%
Dec 31, 2021900.00K275.00K44.00%
Dec 31, 2020625.00K102.00K19.50%
Dec 31, 2019523.00K-201.00K-27.76%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

VCNX News

More News